Kalaris Therapeutics, Inc. · NASDAQ:KLRS
Gilead Sciences, Inc.'s stake in Kalaris Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)
Event Mar 18, 2025 · Filed Mar 20, 2025
Gilead Sciences, Inc.'s stake in Kalaris Therapeutics, Inc. fell to 3.90%, 723,273 shares, as a passive investor on Mar 18, 2025. Filed Mar 20, 2025 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 723,273
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GILEAD SCIENCES, INC. | 3.90% | 723,273 |
Source
Related
- Kalaris Therapeutics, Inc.
- Gilead Sciences, Inc.
- Kalaris Therapeutics, Inc. shareholders
- Form 4 · Srinivas Akkaraju · May 22, 2026
- Schedule 13D/A · Akkaraju Srinivas · May 22, 2026
- Schedule 13G · Rtw Investments, LP · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 22, 2025